Suchergebnisse — DigiBib

Katalog

Ermittle Trefferzahl…

Mehr
4.437 Treffer

4.437 Treffer

Detailansicht für Treffer 1 öffnen

Care Pathway at a Cancer Center for the Administration of Radiometabolic Therapy with 177Lu-PSMA in Patients with Metastatic Castration-resistant Prostate Cancer.

Avila, Carlos ; Cadavid, Tatiana ; et al.

In: Molecular Imaging & Radionuclide Therapy, Jg. 33 (2024-02-01), Heft 1, S. 28-37

Online academicJournal

Zugriff:

Full Text Finder (Volltext)

Wie komme ich dran?
Detailansicht für Treffer 2 öffnen

SNMMI Abstract of the Year: [177Lu]Lu-PSMA-617 extends progression-free survival with manageable safety profile in taxane-naive advanced prostate cancer patients.

In: Medical Letter on the CDC & FDA, 2024-06-25, S. 1252-1252

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 3 öffnen

New Findings Reported from University of California Los Angeles (UCLA) Describe Advances in Prostate Cancer (Tandem Isotope Therapy With 225ac-and 177lu-psma-617 In a Murine Model of Prostate Cancer).

In: Cancer Weekly, 2024-01-30, S. 498-498

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 4 öffnen

Study Results from State University of Campinas (UNICAMP) Broaden Understanding of Prostate Cancer (177LU-PSMA in Metastatic Castration Resistant Prostate Cancer: Preliminary Analysis of A Brazilian Multicentric Study).

In: Drug Week, 2024-05-31, S. 897-897

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 5 öffnen

Data from Department of Urology Provide New Insights into Prostate Cancer (Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer: a meta-analysis).

In: Clinical Trials Week, 2024-06-10, S. 170-170

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 6 öffnen

The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using <superscript>177</superscript>Lu-PSMA.

Ahmadzadehfar, Hojjat ; Aryana, Kamran ; et al.

In: Iranian Journal of Nuclear Medicine, Jg. 26 (2018), Heft 1, S. 2-8

Online academicJournal

Zugriff:

Full Text Finder (Volltext)

Wie komme ich dran?
Detailansicht für Treffer 7 öffnen

Research from University of British Columbia Provides New Data on Prostate Cancer (<superscript>177</superscript>Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice).

In: Clinical Trials Week, 2024-04-08, S. 1250-1250

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 8 öffnen

New Findings Reported from All India Institute of Medical Sciences (AIIMS) Describe Advances in Prostate Cancer ([<superscript>177</superscript>lu]Lu-psma-radioligand Therapy Efficacy Outcomes In Taxane-naive Versus Taxane-treated Patients With Metastatic.

In: Drug Week, 2024-01-19, S. 235-235

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 9 öffnen

Studies from Optum Inc. in the Area of Prostate Cancer Described [Real-world Utilization, Patient Characteristics, and Treatment Patterns Among Men With Localized Prostate Cancer Tested With the 17-gene Genomic Prostate Score(R) (Gps) Assay].

In: Cancer Weekly, 2024-05-21, S. 1123-1123

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 10 öffnen

"Prostate Neoantigens And Their Uses" in Patent Application Approval Process (USPTO 20240139265).

In: Cancer Vaccine Week, 2024-05-20, S. 78-78

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 11 öffnen

Studies from U.S. Food and Drug Administration (FDA) Describe New Findings in Prostate Cancer (Fda Approval Summary: Lutetium Lu 177 Vipivotide Tetraxetan for Patients With Metastatic Castration-resistant Prostate Cancer).

In: Medical Letter on the CDC & FDA, 2024-05-03, S. 1131-1131

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 12 öffnen

Reports from Uppsala University Advance Knowledge in Prostate Cancer (177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry).

In: Cancer Weekly, 2023-10-17, S. 809-809

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 13 öffnen

Data on Prostate Cancer Reported by Researchers at Center Leon Berard (Real Life Experience of Compassionate Use of 177lu-psma-1 for Metastatic Castration-resistant Prostate Cancer Patients In Leon Berard Cancer Centre).

In: Clinical Trials Week, 2024-01-22, S. 135-135

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 14 öffnen

Minority-Inclusive Imaging Biomarker-Based End of Therapy Trial for 177Lu-PSMA-617, a Randomized De-Escalation Theranostic Trial for Metastatic Castrate Resistant Prostate Cancer.

In: AIDS Weekly, 2024-01-22, S. 30-30

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 15 öffnen

Study Results from Instituto Nacional de Investigaciones Nucleares Broaden Understanding of Neuroendocrine Cancer (Improving Overall Survival and Quality of Life in Patients with Prostate Cancer and Neuroendocrine Tumors Using <superscript>177</superscript>Lu-iPSMA...).

In: Cancer Weekly, 2023-08-15, S. 1352-1352

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 16 öffnen

Investigators from Mashhad University of Medical Sciences Have Reported New Data on Prostate Cancer (Quadruplet Therapy In De Novo High-volume Mixed Neuroendocrine Prostate Cancer Using <superscript>177</superscript>lu-psma a Case Report).

In: Cancer Weekly, 2024-03-19, S. 452-452

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 17 öffnen

Reports Summarize Prostate Cancer Findings from Memorial Sloan-Kettering Cancer Center (Lesion Dosimetry for [<superscript>177</superscript>lu]Lu-psma-617 Radiopharmaceutical Therapy Combined With Stereotactic Body Radiotherapy In Patients With Oligometastat.

In: Clinical Trials Week, 2024-01-29, S. 756-756

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 18 öffnen

Researchers from University of California San Francisco (UCSF) Report Details of New Studies and Findings in the Area of Prostate Cancer (Single-dose 177lu-psma-617 Followed By Maintenance Pembrolizumab In Patients With Metastatic Castration-...).

In: Immunotherapy Weekly, 2024, S. 1110-1110

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 19 öffnen

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castrati.

In: Clinical Trials Week, 2023-12-04, S. 285-285

serialPeriodical

Wie komme ich dran?
Detailansicht für Treffer 20 öffnen

University Hospital Frankfurt Researchers Further Understanding of Prostate Cancer (Intermittent Radioligand Therapy with <superscript>177</superscript>Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer).

In: Cancer Weekly, 2023-10-10, S. 1461-1461

serialPeriodical

Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576

sm 576 - 768

md 768 - 992

lg 992 - 1200

xl 1200 - 1366

xxl 1366 -